Current Report Filing (8-k)
05 Maio 2023 - 6:22PM
Edgar (US Regulatory)
0001858912
false
0001858912
2023-05-01
2023-05-01
0001858912
tmb:UnitsEachConsistingOfOneShareOfCommonStockParValue0.0001PerShareAndOneRedeemableWarrantMember
2023-05-01
2023-05-01
0001858912
tmb:SharesOfCommonStockParValue0.0001PerShareIncludedAsPartOfUnitsMember
2023-05-01
2023-05-01
0001858912
tmb:RedeemableWarrantsIncludedAsPartOfUnitsMember
2023-05-01
2023-05-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(D) of the
Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 5, 2023 (May 1, 2023)
GARDINER HEALTHCARE ACQUISITIONS CORP.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
|
001-41185 |
|
86-2899992 |
(State or other jurisdiction of
incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
3107 Warrington Road
Shaker Heights, Ohio |
|
44120 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (216) 633-6708
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of
each exchange on
which registered |
Units, each consisting of one share of common stock, par value $0.0001 per share, and one redeemable warrant |
|
GDNRU |
|
The Nasdaq Stock Market LLC |
Shares of common stock, par value $0.0001 per share |
|
GDNR |
|
The Nasdaq Stock Market LLC |
Redeemable warrants |
|
GDNRW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 |
Entry into a Material Definitive Agreement. |
On May 1, 2023, Gardiner Healthcare Acquisitions
Corp. (the “Company”) issued five unsecured promissory notes (each, a “Promissory Note” and, collectively,
the “Promissory Notes”) to Payees (as defined below), pursuant to which the Company is entitled to borrow an aggregate
of $425,000 for costs, fees and expenses related to the Company’s operations, including those relating to the preparation, negotiation
and consummation of an intended Business Combination (as defined below). All unpaid principal under the Promissory Notes will be due and
payable in full on the earlier of (i) June 27, 2023 (or such later extension date permitted by the Amended and Restated Certificate of
Incorporation, as amended, of the Company (the “Certificate of Incorporation”) in the event the stockholders of the Company
approve a further amendment to the Certificate of Incorporation to extend the period to consummate a business combination) (the “Maturity
Date”) and (ii) the date on which the Company consummates an initial business combination (the “Business Combination”).
The Promissory Notes entered into by the Company
were issued as follows: (i) to Seisun Capital PTY LTD (“Seisun Capital”) for a principal sum of $75,000; (ii) to Guy
Spriggs Trust 12/16 (“Spriggs”) for a principal sum of $200,000; (iii) to Kent Rinker (“Rinker”)
for a principal sum of $50,000; (iv) to Greg Sukenik (“Sukenik”) for a principal sum of $25,000; and (v) to Virginia
Stack (“Stack” and, together with Seisun Capital, Spriggs, and Rinker, each a “Payee” and, collectively,
the “Payees”) for a principal sum of $75,000.
A copy of the form of Promissory Note is filed
with this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference, and the foregoing description of the Convertible
Note is qualified in its entirety by reference thereto.
Sponsor Support Agreement
In connection with entering into the
Promissory Notes, on May 1, 2023, the Payees (with the exception of Stack), and Gardiner Healthcare Holdings, LLC, a Delaware limited liability company
(“Gardiner Sponsor”), entered into a Sponsor Support Agreement (the “Sponsor Support
Agreement”), pursuant to which, among other things, Gardiner Sponsor agreed to assign and transfer to the Payees a certain
number of shares of Common Stock owned by Gardiner Sponsor in accordance with the terms of such Sponsor Support Agreement, as an
inducement for the Payees to make the loans contemplated by the Promissory Notes.
A copy of the Sponsor Support Agreement is filed
with this Current Report on Form 8-K as Exhibit 10.2 and is incorporated herein by reference, and the foregoing description of the Sponsor
Support Agreement is qualified in its entirety by reference thereto.
Item 2.03 |
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. |
The information set forth above in Item 1.01 of
this Current Report on Form 8-K is incorporated by reference herein.
Item 9.01 |
Financial Statements and Exhibits. |
(d) Exhibits:
† Certain confidential information (indicated by brackets
and asterisks) has been omitted from this exhibit because it is both (i) not material and (ii) the type of information that the registrant
treats as private or confidential.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Gardiner Healthcare Acquisitions Corp. |
|
|
|
Date: May 5, 2023 |
By: |
/s/ Marc F. Pelletier |
|
|
Name: |
Marc F. Pelletier |
|
|
Title: |
Chief Executive Officer |
Gardiner Healthcare Acqu... (NASDAQ:GDNR)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Gardiner Healthcare Acqu... (NASDAQ:GDNR)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
Notícias em tempo-real sobre Gardiner Healthcare Acquisition Corporation da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Gardiner Healthcare Acquisitions Corp.